Legis Daily

Protecting Americans from Unsafe Drugs Act of 2023

USA118th CongressHR-2500| House 
| Updated: 4/14/2023
Andy Kim

Andy Kim

Democratic Representative

New Jersey

Cosponsors (1)
John P. Sarbanes (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Protecting Americans from Unsafe Drugs Act of 2023 This bill expands the authority of the Secretary of the Department of Health and Human Services (HHS) to order the recall of controlled substances to cover all drugs. Furthermore, the authority to issue such an order may be delegated to the Director of the Center for Drug Evaluation and Research or the Director of the Center for Biologics Evaluation and Research (or an official senior to either director), whereas currently this authority may only be delegated to the Director of the Center for Drug Evaluation and Research or an official senior to such director. (Both centers are located in the Food and Drug Administration within HHS.)
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 117-6545
Protecting Americans from Unsafe Drugs Act of 2022
Apr 6, 2023
Introduced in House
Apr 6, 2023
Referred to the House Committee on Energy and Commerce.
Apr 14, 2023
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 117-6545
    Protecting Americans from Unsafe Drugs Act of 2022


  • April 6, 2023
    Introduced in House


  • April 6, 2023
    Referred to the House Committee on Energy and Commerce.


  • April 14, 2023
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 118-4697: Protecting PAHPA Act of 2023

Protecting Americans from Unsafe Drugs Act of 2023

USA118th CongressHR-2500| House 
| Updated: 4/14/2023
Protecting Americans from Unsafe Drugs Act of 2023 This bill expands the authority of the Secretary of the Department of Health and Human Services (HHS) to order the recall of controlled substances to cover all drugs. Furthermore, the authority to issue such an order may be delegated to the Director of the Center for Drug Evaluation and Research or the Director of the Center for Biologics Evaluation and Research (or an official senior to either director), whereas currently this authority may only be delegated to the Director of the Center for Drug Evaluation and Research or an official senior to such director. (Both centers are located in the Food and Drug Administration within HHS.)
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 117-6545
Protecting Americans from Unsafe Drugs Act of 2022
Apr 6, 2023
Introduced in House
Apr 6, 2023
Referred to the House Committee on Energy and Commerce.
Apr 14, 2023
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    HR 117-6545
    Protecting Americans from Unsafe Drugs Act of 2022


  • April 6, 2023
    Introduced in House


  • April 6, 2023
    Referred to the House Committee on Energy and Commerce.


  • April 14, 2023
    Referred to the Subcommittee on Health.
Andy Kim

Andy Kim

Democratic Representative

New Jersey

Cosponsors (1)
John P. Sarbanes (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 118-4697: Protecting PAHPA Act of 2023
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted